{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:02:50Z","timestamp":1770523370294,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ijid.2024.107161","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:56:26Z","timestamp":1720540586000},"page":"107161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged \u226575 years (EU-COVAT-1-AGED Part B)"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-2469","authenticated-orcid":false,"given":"Jannik","family":"Stemler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lusine","family":"Yeghiazaryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3777-9006","authenticated-orcid":false,"given":"Christoph","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin Greve-Isdahl","family":"Mohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1823-4174","authenticated-orcid":false,"given":"Antonio-Jos\u00e9","family":"Carcas-Sansuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza Romero","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar Vergara","family":"Mitxeltorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-6265","authenticated-orcid":false,"given":"Birut\u0117","family":"Zablockien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Akova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9979-1671","authenticated-orcid":false,"given":"Ullrich","family":"Bethe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Heringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Salmanton-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4669-690X","authenticated-orcid":false,"given":"Julia","family":"Jeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-0670","authenticated-orcid":false,"given":"Lea","family":"Tischmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-6123","authenticated-orcid":false,"given":"Marouan","family":"Zarrouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnd","family":"C\u00fcppers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7613-8119","authenticated-orcid":false,"given":"Lena M.","family":"Biehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3928-2503","authenticated-orcid":false,"given":"Sibylle C.","family":"Mellinghoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Nacov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4479-6322","authenticated-orcid":false,"given":"Julia M.","family":"Neuhann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanne","family":"Sprute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Fr\u00edas-Iniesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riya","family":"Negi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurvin","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro Garc\u00eda","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W.G.","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Lammens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Hotterbeekx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3009-2862","authenticated-orcid":false,"given":"Katherine","family":"Loens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Malhotra-Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Kumar-Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Posch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9599-3137","authenticated-orcid":false,"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107161_bib0001","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2024.107161_bib0002","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2024.107161_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111357","article-title":"The conundrum of human immune system \"senescence\"","volume":"192","author":"Pawelec","year":"2020","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.ijid.2024.107161_bib0004","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2024.107161_bib0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S1473-3099(22)00271-7","volume":"22","author":"Munro","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107161_bib0006","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2024.107161_bib0007","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S1473-3099(22)00292-4","article-title":"Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study","volume":"22","author":"Monge","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107161_bib0008","unstructured":"Moderna. Moderna announces preliminary booster data and updates strategy to address omicron variant [press release], 2021, https:\/\/investors.modernatx.com\/news\/news-details\/2021\/Moderna-Announces-Preliminary-Booster-Data-and-Updates-Strategy-to-Address-Omicron-Variant\/default.aspx; 2021 [accessed 20 July 2024]."},{"key":"10.1016\/j.ijid.2024.107161_bib0009","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.vaccine.2023.05.006","article-title":"VACCELERATE Site Network. VACCELERATE Site Network: real-time definition of clinical study capacity in Europe","volume":"41","author":"Salmanton-Garc\u00eda","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107161_bib0010","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1016\/j.vaccine.2022.05.022","article-title":"VACCELERATE Volunteer Registry: a European study participant database to facilitate clinical trial enrolment","volume":"40","author":"Salmanton-Garc\u00eda","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107161_bib0011","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1016\/j.vaccine.2023.10.029","article-title":"Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: a randomised VACCELERATE trial in adults \u226575 years (EU-COVAT-1)","volume":"41","author":"Neuhann","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107161_bib0012","doi-asserted-by":"crossref","first-page":"20373","DOI":"10.1038\/s41598-022-24409-w","article-title":"Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years","volume":"12","author":"Durier","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2024.107161_bib0013","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.mad.2005.03.008","article-title":"The inflammatory response to vaccination is altered in the elderly","volume":"126","author":"El Yousfi","year":"2005","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.ijid.2024.107161_bib0014","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2024.107161_bib0015","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.vaccine.2022.12.035","article-title":"Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older","volume":"41","author":"Saiag","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107161_bib0016","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2024.107161_bib0017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.smim.2018.10.010","article-title":"Vaccination in the elderly: the challenge of immune changes with aging","volume":"40","author":"Ciabattini","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ijid.2024.107161_bib0018","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/infdis\/jiy382","article-title":"Herpes zoster vaccines","volume":"218","author":"Cunningham","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107161_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123367","article-title":"Role of senescence and aging in SARS-CoV-2 infection and COVID-19 disease","volume":"10","author":"Lynch","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijid.2024.107161_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2023.04.012","article-title":"Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial","volume":"87","author":"Liu","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2024.107161_bib0021","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41564-022-01272-z","article-title":"Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines in US veterans","volume":"8","author":"Dickerman","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijid.2024.107161_bib0022","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(23)00058-0","article-title":"Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study","volume":"23","author":"Chemaitelly","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107161_bib0023","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1473-3099(23)00199-8","article-title":"Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged \u226518 years: a randomised, double-blind, phase 2b trial","volume":"23","author":"Wu","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107161_bib0024","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-023-06753-7","article-title":"Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting","volume":"625","author":"Yisimayi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2024.107161_bib0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107161_bib0026","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/vaccines10010086","article-title":"Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine","volume":"10","author":"Kanokudom","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2024.107161_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108860","article-title":"Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey","volume":"232","author":"Shapiro Ben David","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijid.2024.107161_bib0028","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1186\/s13063-022-06791-y","article-title":"A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults \u226575 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network","volume":"23","author":"Neuhann","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.ijid.2024.107161_bib0029","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1038\/s41467-023-42717-1","article-title":"Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time","volume":"14","author":"Kenny","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2024.107161_bib0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2024.107161_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.832889","article-title":"Predicted HLA class I and Class II epitopes from licensed vaccines are largely conserved in new SARS-CoV-2 omicron variant of concern","volume":"13","author":"L\u00f3pez","year":"2022","journal-title":"Front Immunol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224002327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224002327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T21:18:43Z","timestamp":1728508723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224002327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"alternative-id":["S1201971224002327"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107161","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged \u226575 years (EU-COVAT-1-AGED Part B)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107161"}}